Search

Erika K Hammarlund

from Sunnyvale, CA
Age ~60
Get Report
Also known as:
Erika Kristina Hammarlund, Erika K Hammarfund, Erica Hammarlund
Phone and address:
1484 Chukar Ct, Sunnyvale, CA 94087
(503) 693-8394
Related to:
Per HammarfundPer Hammarlund, 29
Connected to:
Ashley Hammarmeister, 66Ashley Hammarmeister, 40Irene E Hammarlund, 96Ole Hammarlund, 82Anna J Hammarskjold, 52Brian F Hammarstrom, 36Christian U Hammarskjold, 61Dan J Hammarsten, 77Meaghan M Hammarsten, 41Eric A Hamme, 50

Erika Hammarlund Phones & Addresses

  • 1484 Chukar Ct, Sunnyvale, CA 94087 (503) 693-8394
  • 2601 2Nd St, Hillsboro, OR 97124
  • 2601 NE 2Nd Dr, Hillsboro, OR 97124

Work

Company: Ohsu | oregon health & science university Sep 2001 to Dec 2016 Position: Research associate at ohsu

Education

Degree: Masters School / High School: Stockholm University 1985 to 1990 Specialities: Immunology

Skills

Immunology • Flow Cytometry • Facs Analysis • Virology • Elisa • Cell Culture • Immunohistochemistry • Monoclonal Antibodies • Elispot • Plaque Assay

Languages

English • Swedish

Industries

Hospital & Health Care

Resumes

Resumes

Erika Hammarlund Photo 1

Erika Hammarlund

View page
Location:
3181 west Sam Jackson Park Rd, Portland, OR 97239
Industry:
Hospital & Health Care
Work:
Ohsu | Oregon Health & Science University Sep 2001 - Dec 2016
Research Associate at Ohsu
Pfizer Jan 1989 - Dec 1996
Research Associate
Education:
Stockholm University 1985 - 1990
Masters, Immunology
Skills:
Immunology
Flow Cytometry
Facs Analysis
Virology
Elisa
Cell Culture
Immunohistochemistry
Monoclonal Antibodies
Elispot
Plaque Assay
Languages:
English
Swedish

Publications

Us Patents

Inactivating Pathogens With Hydrogen Peroxide For Vaccine Production

View page
US Patent:
20070031451, Feb 8, 2007
Filed:
Aug 7, 2006
Appl. No.:
11/500763
Inventors:
Mark Slifka - Portland OR, US
Shirley Carter - Lake Oswego OR, US
Erika Hammarlund - Hillsboro OR, US
Paul Yoshihara - Portland OR, US
International Classification:
A61K 39/12
A61K 39/02
A61K 33/40
US Classification:
424204100, 424234100, 424616000
Abstract:
The present disclosure provides methods for producing a vaccine composition containing a pathogen that is rendered noninfectious by exposure to hydrogen peroxide. The methods disclosed herein are suitable for the preparation of vaccines for a wide variety of pathogens, including viruses, bacteria and parasites. The disclosure also provides vaccine compositions (medicaments) containing a pathogen inactivated by exposure to hydrogen peroxide. Methods for eliciting an immune response in a subject by administering vaccine compositions containing a hydrogen peroxide inactivated pathogen are also provided.

Compositions And Methods For Diagnosis And Treatment Of Orthopoxviruses

View page
US Patent:
20100316653, Dec 16, 2010
Filed:
Jun 13, 2005
Appl. No.:
11/629417
Inventors:
Mark Slifka - Portland OR, US
Paul Yoshihara - Portland OR, US
Erika Hammarlund - Hillsboro OR, US
Assignee:
Oregon Health & Science University - Portland OR
International Classification:
A61K 39/42
C12Q 1/70
C40B 30/04
C40B 40/10
C07K 16/08
US Classification:
4241591, 435 5, 506 9, 506 18, 5303871, 5303873, 5303883
Abstract:
In particular aspects, the invention provides a novel approach for the systematic analysis and identification of biologically relevant epitopes (SABRE). SABRE-identified polypeptides have diagnostic (e.g., polypeptide arrays, etc.) and/or therapeutic (e.g., vaccines, etc.) utility, and utility for developing monoclonal antibodies having diagnostic and/or therapeutic utility (e.g. for detecting and/or preventing orthopoxvirus infection). Preferred aspects provide high-throughput assays for detecting specific orthopoxvirus infection, for detecting orthopoxvirus-specific immune response, or for dual (parallel) determination of both orthopoxvirus immune response and orthopoxvirus infection. Additional preferred and surprising aspects provide novel high-throughput methods for detecting ‘protective immunity’ against orthopoxviruses (e.g., for detecting protective immunity against smallpox virus and monkeypox virus), based on anti-vaccinia virus serum antibody levels. The inventive diagnostic assays are rapid, high-throughput and suitable for ‘point-of-care’ implementations.

Inactivating Pathogens With Oxidizing Agents For Vaccine Production

View page
US Patent:
20130004525, Jan 3, 2013
Filed:
Feb 24, 2012
Appl. No.:
13/405082
Inventors:
Mark K. Slifka - Banks OR, US
Shirley Villadiego - Miami FL, US
Erika Hammarlund - Hillsboro OR, US
Paul Yoshihara - Portland OR, US
Assignee:
Oregon Health and Science University - Portland OR
International Classification:
A61K 39/00
A61P 37/04
US Classification:
4241841
Abstract:
The present disclosure provides methods for producing a vaccine composition containing a pathogen that is rendered noninfectious by exposure to hydrogen peroxide. The methods disclosed herein are suitable for the preparation of vaccines for a wide variety of pathogens, including viruses, bacteria and parasites. The disclosure also provides vaccine compositions (medicaments) containing a pathogen inactivated by exposure to hydrogen peroxide. Methods for eliciting an immune response in a subject by administering vaccine compositions containing a hydrogen peroxide inactivated pathogen are also provided.

Suppressors Of Mature T Cells

View page
US Patent:
20140335115, Nov 13, 2014
Filed:
May 7, 2014
Appl. No.:
14/272355
Inventors:
Dina Alzhanova - Beaverton OR, US
Klaus Frueh - Portland OR, US
Erika Hammarlund - Hillsboro OR, US
Mark Slifka - Banks OR, US
Assignee:
Oregon Health & Science University - Portland OR
International Classification:
C07K 14/005
C12N 7/00
US Classification:
4241861, 4353201, 514 44 R
Abstract:
Disclosed herein is a viral polypeptide and homologs thereof that inhibit an immune response, particularly the response of memory and effector CD4 and CD8 T cells.

Inactivating Pathogens With Oxidizing Agents For Vaccine Production

View page
US Patent:
20140242115, Aug 28, 2014
Filed:
May 5, 2014
Appl. No.:
14/269708
Inventors:
- Portland OR, US
Shirley Villadiego - Miami FL, US
Erika Hammarlund - Hillsboro OR, US
Paul Yoshihara - Portland OR, US
Assignee:
Oregon Health and Science University - Portland OR
International Classification:
A61K 39/285
US Classification:
4242321
Abstract:
The present disclosure provides methods for producing a vaccine composition containing a pathogen that is rendered noninfectious by exposure to hydrogen peroxide. The methods disclosed herein are suitable for the preparation of vaccines for a wide variety of pathogens, including viruses, bacteria and parasites. The disclosure also provides vaccine compositions (medicaments) containing a pathogen inactivated by exposure to hydrogen peroxide. Methods for eliciting an immune response in a subject by administering vaccine compositions containing a hydrogen peroxide inactivated pathogen are also provided.
Control profile
Erika K Hammarlund from Sunnyvale, CA, age ~60 Get Report